OOIR: Observatory of International Research

Papers

(The TQCC of Current Radiopharmaceuticals is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Biological Efficacy of Ionizing Radiation Sources on 3D Organotypic Tissue Slices Assessed by Fluorescence Microscopy	36
Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas	20
Feasibility of a Scale-down Production of [68Ga]Ga-NODAGA-Exendin-4 in a Hospital Based Radiopharmacy	20
Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the First Nuclear Medicine Imaging Probe for ETRA Brain Receptor	12
Preface	12
The Central Composite Design and Artificial Neural Network Coupled with Genetic Algorithm in Optimization and Modeling of the Radiolabeling Process of ¹⁷⁷Lu-hydroxyapatite as a Potential Ra	10
Cyclotron Production of Non-conventional Theranostic Radionuclides and Radiopharmaceuticals	9
Prediction of Recurrence using a Stacked Denoising Autoencoder and Multifaceted Feature Analysis of Pretreatment MRI in Patients with Nasopharyngeal Carcinoma	9
Left Ventricular Wall Motion as an Additional Valuable Parameter in Diabetic Patients with Normal Myocardial Perfusion Imaging	8
The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell	8
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt	8
The Alleviating Effect of Herniarin Against Ionizing Radiation-Induced Genotoxicity and Cytotoxicity in Human Peripheral Blood Lymphocytes	7
Evaluating the Mitigation Effect of Spirulina Against Radiation-Induced Heart Injury	7
Astatine-211 Radiopharmaceuticals; Status, Trends, and the Future	7
A Novel Dual-labeled Peptide for Multimodal Imaging of EGFR with L858R Mutation	6
Evaluation in Terms of Dosimetry and Fertility of F18-FDG and Ga68- PSMA in Prostate Cancer Imaging: A Simulation with GATE	6
Harnessing Radionuclides: Unveiling the Promising Role of Radiopharmaceuticals in Cancer Theranostics and Palliative Care	6
Optimization of SUV with Changing the Dose Amount in F18-FDG PET/CT of Pediatric Lymphoma Patients	5
Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation- Induced Small Intestine Injury	5
Preface	5
Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts	5
Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches	5
Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins	5
Multimodality Imaging Evaluation of Nasal Rhabdomyosarcoma in Adults: A Case Report and Literature Review	5
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy	5

Acknowledgement to Reviewers	5
Assessment of Radiation Exposure Dose for Nuclear Medicine Workers from 18F-FDG, 99mTc MDP, and 99mTc	5
The Impact of Radiolabeled Nanomaterials	5
Comparative Study of Extremely Low-Frequency Electromagnetic Field, Radiation, and Temozolomide Administration in Spheroid and Monolayer Forms of the Glioblastoma Cell Line (T98)	4
Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study	4
The Impact of HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) on the Psychological Well-being of Gynecological Cancer Patients	4
Detailed Chemistry Studies of 225Actinium Labeled Radiopharmaceuticals	4
Estimation of Human Absorbed Dose of 188Re-Hynic-Bombesin Based on Biodistribution Data in Rats	4
Promising Radiopharmaceutical Tracers for Detection of Cardiotoxicity in Cardio-oncology	4
Toxicity and Tolerability of 177Lu-DOTA-TATE PRRT with a Modified Administered Activity Protocol in NETs of Variable Origin – A Phase 2 Registry Study	4
Synthesis of 225Ac-PSMA-617 for Preclinical Use	4
Preclinical Investigation of Radiopharmaceuticals: An Accurate and Multidisciplinary Approach	4
Theranostics of Metastatic Prostate Cancer Applying 64Cu/18F/68Ga PSMA PET-CT and 177Lu Radiopharmaceuticals	4
Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review	4
Current Advancement and Future Prospects: Biomedical Nanoengineering	4